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max%WMA
Superior Outcome with Rotational Atherectomy
Combined with Balloon Angioplasty Compared to
Balloon Angioplasty Alone: Results of a Case
Control Study
Positive Markers n = 3
Negative Markers n = 6
rotic debris from the ROTA site as defined by regional transient dysynergy
resolving completely by 24 hours post ROTA. Microinfarction in the setting
of myocardial stunning is an additional explanation for this phenomena, and
the prevalence of microinfarction in the setting of stunning has not been
determined. We screened selected patients with transient WMA post-ROTA
for troponin I, myoglobin and CKMB release as a screening for myocardial
necrosis.
Results: We studied 9 patients: 8/9 male, 7/9 LAD lesion, 2/9 RCA lesion.
All patients had adjunctive post ROTA balloon angioplasty except one who
required a 3.0 mm Cook stent. In this welect patient group wall motion was
normal in all patients before intervention and within 24 hours following ROTA.
Following ROTA peak onset of WMA ranged from 5-27 min, mean maximal
%WMA 28.3% ± 11.89%, and median time to full recovery of wall motion
was 88 min ± 655 min.
Evidence of myocardial necrosis (positive markers) was present in 3/9 pa-
tients following ROTA with the evolution of transient ECG T wave abnormali-
tics 3/3, increased CKMB > 7.5 ng/ml (range 25-72) 2/3, increased myoglobin
level 2/3 and increased troponin I > 1.35 ng/ml (range 3.88-15.9) in 3/3 pa-
tients. None of the remaining patients developed any indicator of myocardial
necrosis.
Compared to BA alone, RAIBA resulted in a larger final MLD, greater acute
gain and less severe % stenosis and extent of dissection. These data indicate
that the acute angiographic outcome achieved by combining RA and BA is
superior to that of BA alone.
The ideal burr size for rotablator atherectomy (MRA) is unknown. MRA was
performed on 160 consecutive patients and reference artery diameter, di-
ameter stenosis (OS) baseline, DS after MRA. and final OS were measured
by quantitative angiography. Final burr to artery (B/A) ratios were calculated
and divided into two groups: B/A < 0.7 (n = 112) and B/A > 0.7 (n = 48).
Ouantitative angiographic results, composite major angiographic complica-
tions (severe dissection, perforation, no reflow, and abrupt closure) and ma-
jor clinical complications (death, bypass surgery, and myocardial infarction)
were analyzed for both groups. Baseline OS was 70% in both groups.
David C. Burkey, Barry L. Sharaf, Nicholas J. Miele, David O. Williams. Rhode Island
Hospital, Brown University, Providence, Rhode Island
Although a strategy of "debulk and dilate" may appear intuitively superior
to balloon angioplasty (BA) alone, data supporting this concept are lacking.
Accordingly, we performed angiographic laboratory analyses of 21 patients
(pts) treated with rotational atherectomy (RA) and adjunctive aggressive BA
and compared their immediate angiographic outcomes to 21 selected pts
treated with BA only. The BA only group was chosen from a large PTCA
database to identify a "matched" SA pt for each of the RA pts. Matching
was based on clinical and coronary angiographic characteristics. When the
two groups were compared at baseline, there were no differences (p > 0.05)
in terms of age, gender, target lesion location, % stenosis, minimal lumen
diameter (MLD), reference diameter, TIMI flow grade, lesion length or pres-
ence of calcium, thrombus, or eccentricity. The angiographic results of final
outcome were:
Conclusion: Despite prolonged recovery times and extensive transient
%WMA, reflective of myocardial stunning, these factors were not predictive
of troponin I release following successful ROTA. Thus microinfarction may
occur in the context of myocardial stunning, yet the dominant mechanism
transient WMA is likely to be myocardial stunning.
Charactenstic (mean ± 1 SD) BAAlone RNBA p
Reference diameter (mm) 26± 0.4 2.70 ± 04 0.800
MLD(mm} 1.7 ± 0.4 2.1 ± 0.3 0.005
% Stenosis 33.2 ± 136 18.9 ± 10.1 0.000
Acute gain {mml 1.1 ± 0.5 14± 0.3 0.038
Dissection (% pts) 28.6 9.5 0.116
Extent of dissection (mm2) 2.2 ± 5.1 09± 0.3 0.057
What is the Ideal Burr Size for Rotablator
Atherectomy?
Barry M. Kaplan, William W. O'Neill, Mark Dooris, Venu M. Reddy, Cindy L. Grines,
Robert D. Safian. William Beaumont Hospital, Royal Oak, Michigan
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Plaque Pulverization During Rotablator
Atherectomy: Does It Impair Coronary Flow
Dynamics?
- P< 0.001 --.-..
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Before After p value
MAP (mmHg) 101 ± 5 94 ±4 ns
HR (bts/min) 72 ± 2 74 ± 3 ns
Prox. Lumen Diam {mm} 3.44 ± 01 3.50 ± 0.2 ns
Minimal Lumen Diam (mm) 1.3 ± 01 2.6 ± 02 005
APV(cm/sl 20 ± 3 36 ± 5 0.05
DSVR (ratio) 1.8±0.8 15 ± 0.6 ns
CSF (mllmin) 81 ± 14 154 ± 18 0.05
CVR (mmhg/mllmin) 1.74 ± 0.4 0.74 ± 0.4 005
CFR (ratio) 1.24 ± 01 1.6 ± 0.1 ns
Rotablator atherectomy (MRA) results in pulverization of plaque which is
cleared by the microcirculation, but the impact of microembolization on coro-
nary blood flow is unknown. Accordingly, coronary flow dynamics were stud-
ied before, immediately after MRA, and after adjunctive PTCA using Doppler
Flowires proximal and distal to the stenosis in 15 patients (LAD 8, LCX 3, RCA
4). Stable phasic signals were recorded distally in the same angiographic po-
sition and basal average peak velocity (APV) and diastolic to systolic velocity
ratio (DSVR) were measured. There were significant decreases (p < 0.007) in
diameter stenosis assessed by quantitative angiography from baseline (63
± 17%) after MRA (49 ± 18%) and after adjunctive PTCA (28 ± 12%). Heart
rate and blood pressure did not change at any stage. There were significant
increases in basal APV and DSVR after MRA and adjunctive PTCA:
DISTAL AVERAGE PEAK 3 DISTAL DIASTOLIC/SYSTOLIC
VELOCITY VELOCITY RATIO
2.5
Conclusion: 1. Despite tissue pulverization and microembolization, Rotab-
lator atherectomy did not result in detectable impairment in coronary blood
flow. 2. Average peak velocity and diastolic/systolic velocity ratio improve af-
ter MRA. 3. Adjunctive PTCA significantly contributes to the improvement in
distal coronary blood flow after MRA.
landmark were recorded before and after PTCRA. Doppler measurements
were made before and after PTCRA and adjunctive balloon. Average Peak
Velocity (APV) and Diastolic/Systolic Velocity ratio (DSVR) were measured
distal to the lesion. Coronary Flow Reserve (CFRI was assessed with adeno-
sine (24 to 30 JLg i.c.). Estimated coronary blood flow (CBF) and coronary
vascular resistances were calculated by standard formulae. Resu/ts: Before
PTCRA, all Pts had TIM I-III Flow. Immediately after PTCRA, 2 Pts had TIM I-I
Flow, 4 Pts had TIMI-II Flow, and 4 Pts had TIMI-III Flow. In all Pts however,
the frame to opacification increased significantly from 49 ± 12 to 118 ± 47
frames (p < 0.05). After the administration of nitroglycerin i.e. (10/10 Pts) and
verapamil. i.e. (2/10 Ptsl. TIMI-1I1 Flow was restored in all Pts and the frame
to opacification returned to baseline (50 ± 9 frames). The following are the
coronary hemodynamics after PTCRA + adjunctive balloon + nitroglycerin
+ verapamil. Results (mean ± semi:
Transient wall motion abnormalities (WMA) have been found following rota-
tional coronary atherectomy (ROTA) in the majority of patients assessed by
serial echocardiography. A possible mechanism of transient WMA in this set-
ting is myocardial stunning secondary to distal embolization of atheroscle-
Conclusions: 1) Immediately after PTCRA, the reduction in CBF is likely
due to coronary spasm since this spasm was rapidly reversed by of coro-
nary vasodilators. 2) Immediately after PTCRA + adjunctive balloon, there
is an increase in APV, estimated CBF and a fall in CVR. Despite this bene-
ficial hemodynamic profile, the CFR remained abnormal. suggesting either
ischemic reactive hyperemia or a persistent abnormality in the microcircula-
tuion.
Transient Wall Motion Abnormalities Following
Rotational Coronary Atherectomy are Reflective
of Myocardial Stunning More than Microinfarction
Gordon S. Huggins, Michael J.A. Williams, Jane Yang, Charles J. Dow, Roger
J. Hajjar, Michael A. Picard, Igor F. Palacios. Massachusetts General Hospital, Boston,
MA
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Rotational Atherectomy in Chronic Total
Occlusions
$ 5.055 18%
$ 2,670 10%
$13,333 49%
90% Leg infection
76% SVT
133% Any neuro compl
The Monetary Cost of Complications After Bypass
Surgery: The Achilles' Heel of Contract Pricing
New dialysis $36,436
Intubated >48 hrs $24,535
Pneumonia $20,847
Conclusion: Postoperative complications add large. incremental costs to
CABG surgery. and can be more expensive than the basic direct costs of
the procedure itself. By knowing the incidence and costs of complications,
contract prices can be adjusted to more accurately reflect true direct costs.
Timothy A. Denton, George A. Diamond, Jack M. Matloff. Cedars-Sinai Medical
Center, Los Angeles, Califomia
operation, serum albumin levels of less than 4 mg/dl, low body mass index,
history of congestive heart failure, atrial arrhythmia, cerebral vascular dis-
ease, chronic pulmonary disease, anemia. and blood urea nitrogen levels
greater than 29 mg/dl. A cumulative clinical risk score (CRS) was developed
by assigning each factor a score of 1 to 7 based on the predictive power. The
mean CRS for Groups 1, 2 and 3 were 1.5 ± 4.9, 5.3 ± 3.2 and 9.0 ± 4.5.
respectively (p = 0.0001). The model was prospectively validated on 1235
CAB surgery patients from January 1. 1993 to April 30. 1994. Postoperative
morbidity was stratified by CRS points as low 10-21. moderate (3-5), high (6-
81 and extremely high (::,:9). The validation group morbidity rates fell within
the 95% confidence interval of the predicted rates in each category of risk.
Preoperative patient variables can predict postoperative morbidity for CAB
patients. Significant cost reduction can only be accomplished by reducing
postoperative morbidity. The ability to predict morbidity risk provides data
for improved patient selection and for development of targeted protocols to
reduce specific complications.
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Contract pricing among providers is being used as a method to control the
costs of health care. To estimate a contract price. providers must take into
account not only the direct costs of uncomplicated procedures. but the incre-
mental costs of complications. Accordingly, we determined the incremental
costs of postoperative complications in a series of 722 consecutive patients
(3/12/90 to 3122/94) undergoing routine CABG (DRG 107 - CABG without
catheterization).
We identified 31 prospectively collected candidate variables from the peri-
operative period and 15 routinely collected complications. Total direct costs
were obtained from the hospital central financial system. Only patients who
survived to discharge were included in the analysis. Forward. stepwise. mul-
tiple linear regression was used to determine the incremental costs of com-
plications above the cost of an uncomplicated procedure.
Of the candidate variables. 6 perioperative variables (age, angina CHA
class. non-use of internal thoracic artery, widow(er), peripheral vascular dis-
ease, hypercholesterolemia), and 6 complications contributed to the direct
costs of CABG. The following table shows the incremental cost of each post-
operative complication and its percent of the average direct cost of CABG
($27,400)
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Nowa Omoigui, Joan Booth, Mark Reisman, Irving Franco, Patrick Whitlow,
Multicenter Rotablator Registry. The Cleveland Clinic Foundation, Cleveland, OH
The purpose of this study was to evaluate the success rate, complication pro-
file and predictors of outcome of rotational atherectomy (RA) after guidewire
crossing of chronic total occlusions (CTO). 145 total occlusions were treated
in 139 procedures between 1988 and 1993. Of these, there were 112 sin-
gle lesion procedures. Compared to pts with non-total occlusions (NTOI, pts
with CTO were more likely to be male, younger and have a prior MI, but less
likely to present with unstable angina or to have diabetes. Lesions were more
likely type C (68.7% vs 15.1 %, P < 0.0001) and longer (14.8 ± 7.8 vs 8.0 ±
5.6 mm, p < 0.0001). Mean baseline stenosis was 100.0%. Post-Rotablator
stenosis was 45.6 ± 17.5%. Post-adjunctive balloon stenosis was 24.6 ±
15.9% while final residual stenosis was 26.9 ± 16.8%. The maximum mean
burr size was 1.8 ± 0.26 mm while average vessel diameter was 2.74 ± 0.65
mm. Success without major complications occurred in 91.0%. Dissection
occurred in 18.0%, acute in-lab closure in 3.6%, post-Cath lab reocclusion in
3.6%, emergency bypass surgery on 0%, death in 1.4% and NOMI in 4.3% of
pts. Based on 49.2% angiographic follow-up, restenosis occurred in 62.5%
of pts. Univariate predictors of RA success were pt age (p = 0.02), lesion ec-
centricity (p = 0.04) and vessel diameter (p ~ 0.02). In a multivariable logistic
regression model, only larger vessel diameter remained as an independent
predictor of success (2.8 ± 0.6 vs 2.0 ± 0.5 mm). Older age (p ~ 0.04) and
diabetes (p ~ 0.01) were univariate predictors of restenosis. However, in the
final multivariable logistic model, only diabetes remained a significant pre-
dictor.
In conclusion, RA for the treatment of CTO has acceptable success and
restenosis. Non-diabetics with relatively larger vessel diameter appear to
benefit most.
There were significant correlations of B/A ratio (p = 0.051 and OS after
MRA (p ~ 0.01) with lower final OS.
Conclusions: For Rotablator, final burr/artery ratio >0.7 resulted in signifi-
cantly better luminal enlargement compared to burr/artery ratio <0.7 and did
not lead to increased major clinical and angiographic complications. These
data should be evaluated in larger prospective randomized trials.
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In an effort to identify areas of high cost for coronary artery bypass (CAB)
surgery. we used logistic regression methods to predict patients at risk for
postoperative morbidity. The predictive model was derived from 1567 con-
secutive isolated CAB cases performed between July 1, 1991 and Decem-
ber 31, 1992. The patients were categorized into 3 groups: Group 1 IN =
756,48%) no complications, Group 2 (N = 560, 36%) minor complications,
and Group 3 (N = 251, 16%) major complications with extended stay and/or
death. Estimated hospital costs were 3.5 times higher for Group 3 than
Group 1, and 2 times higher for Group 2 than Group 1. The following patient
factors were found to be significant independent predictors of morbidity,
listed in decreasing order of importance: preoperative cardiogenic shock,
emergency surgery, severe left ventricular dysfunction, cardiac laboratory
induced cardiac collapse, increasing age, diabetes mellitus, high serum cre-
atinine levels, peripheral vascular disease, cardiomegaly, female gender, re-
Curtis A. Prejean, Guo-Wen Sun, Manuel R. Estioko. Gregory L. Kay. The Heart
Institute, The Good Samaritan Hospital, Los Angeles. California
Influence of risk factors on cerebrovascular accidents (CVA) in cardiac
surgery has been investigated in several studies, but no one has identified
differences in risk factors on intraoperative CVA (I-CVA) and postoperative
CVA (P-CVA). I-CVA is identified when evidence of CVA is seen as patient
emerges from anesthesia and P-CVA is identified if after emerging from
anesthesia normally, signs of CVA then appear. To explore proper preventive
strategies for each CVA. data were reviewed in 4351 adult patients who un-
derwent cardiac surgery between 1/1/90 and 6/30194. Sixty (1.38%) patients
suffered I-CVA and 53 (1.24%) patients experienced P-CVA. CVA patients are
older (I-CVA: 69.6 vs. 64.2, p < 0.001; P-CVA: 70.1 vs. 64.1, P < 0.001) and
I-CVA shows a higher proportion of females (45.0% vs. 30.0%. p ~ 0.01).
The rates of I-CVA and P-CVA are 1.48% and 1.34% for isolated CABG pa-
tients (n = 3037). 0.28% and 0.70% for isolated valve patients (n = 713).
1.90% and 1.69% for patients who undervvent combined procedures (n =
422),2.79% and 0.57% for other surgeries (n = 179). Patient age (p < 0.001)
and proportion of females (p < 0.0011 differed by procedures (CABG: 64.6 ±
10.4.25.0%; Valve: 60.4 ± 15.7.46.1 %; CABG + Valve: 704 ± 9.0, 34.8%;
others: 58.4 ± 16.2.44.7%). In order to adjust influence of preoperative risk
factors on each CVA. stepwise logistic regression was applied to a subset
of isolated CABGs.
Influence of Preoperative Risk Factors on
Intraoperative and Postoperative
Cerebrovascular Accidents in Cardiac Surgery
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A Prospective Clinical Risk Score for Predicting
Morbidity After Coronary Artery Bypass Surgery
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